Novartis breast cancer drug Kisqali wins EU approval
Source: Pharma Times Novartis has announced the launch of its new breast cancer drug Kisqali in...
WHAT'S UP IN
Aromatase inhibitor
Ribociclib Improves Survival in Post-Menopausal Women With Metastatic Breast Cancer
246,660 women will be diagnosed with breast cancer in 2016, and 40,450 women will die from the...
MD Anderson-led study finds ribociclib improves progression-free survival for women with metastatic breast cancer
IMAGE: This is Gabriel Hortobagyi, M.D. view more Copenhagen, Denmark – In a randomized,...
Study finds ribociclib improves progression-free survival for women with metastatic breast cancer
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer...
